Immunomodulating effects of antibiotics used in the prophylaxis of bacterial infections in advanced cirrhosis

Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013

(2014) Rajiv Jalan et al.   JOURNAL OF HEPATOLOGY

VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis

(2014) Elisabet Sánchez et al.   LIVER INTERNATIONAL

Pathological bacterial translocation in liver cirrhosis

(2013) Reiner Wiest et al.   JOURNAL OF HEPATOLOGY

Protective effect ofBifidobacterium pseudocatenulatumCECT7765 against induced bacterial antigen translocation in experimental cirrhosis

(2013) Alba Moratalla et al.   LIVER INTERNATIONAL

High Prevalence of Antibiotic-Resistant Bacterial Infections Among Patients With Cirrhosis at a US Liver Center

(2012) Puneeta Tandon et al.   Clinical Gastroenterology and Hepatology

Toll-Like Receptor 2–Mediated Intestinal Injury and Enteric Tumor Necrosis Factor Receptor I Contribute to Liver Fibrosis in Mice

(2012) Phillipp Hartmann et al.   GASTROENTEROLOGY

Management of bacterial infections in cirrhosis

(2012) Javier Fernández et al.   JOURNAL OF HEPATOLOGY

Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study

(2011) Javier Fernández et al.   HEPATOLOGY

Ciprofloxacin inhibits advanced glycation end products-induced adhesion molecule expression on human monocytes

(2010) S Mori et al.   BRITISH JOURNAL OF PHARMACOLOGY

Peritoneal macrophage priming in cirrhosis is related to ERK phosphorylation and IL-6 secretion

(2010) Antonio J. Ruiz-Alcaraz et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis

(2010) Vasiliki Arvaniti et al.   GASTROENTEROLOGY

Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis

(2010) Pablo Bellot et al.   HEPATOLOGY

Interleukin-10-mediated heme oxygenase 1-induced underlying mechanism in inflammatory down-regulation by norfloxacin in cirrhosis

(2010) Isabel Gómez-Hurtado et al.   HEPATOLOGY

Proteomic evidence of bacterial peptide translocation in afebrile patients with cirrhosis and ascites

(2010) Rocío Caño et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Norfloxacin Modulates the Inflammatory Response and Directly Affects Neutrophils in Patients With Decompensated Cirrhosis

(2009) Pedro Zapater et al.   GASTROENTEROLOGY

Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis

(2009) Beate Appenrodt et al.   HEPATOLOGY

Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis

(2008) Rubén Francés et al.   HEPATOLOGY